Alexander Gerbes
Overview
Explore the profile of Alexander Gerbes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
3889
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wong C, van den Broek W, Doody G, Fischer M, Leech M, De Ponti F, et al.
MedEdPublish (2016)
. 2024 Mar;
10:64.
PMID: 38486552
This article was migrated. The article was marked as recommended. Medical faculties have the responsibility to train tomorrow's doctors and in a crisis face the challenge of delivering students into...
2.
Maiwall R, Piano S, Singh V, Caraceni P, Alessandria C, Fernandez J, et al.
Hepatology
. 2023 Dec;
79(5):1019-1032.
PMID: 38047909
Background: The administration of an appropriate empirical antibiotic treatment is essential in cirrhosis and severe bacterial infections. We aimed to investigate the predictors of clinical response of empirical antibiotic treatment...
3.
Gu W, Zeleke Y, Hortlik H, Schaaf L, Uschner F, Schulz M, et al.
Hepatol Commun
. 2023 Sep;
7(10).
PMID: 37708430
Background: The number of complications in patients admitted for cirrhosis has increased over time. Portal hypertension is the driver of many complications of cirrhosis. TIPS placement is the most effective...
4.
Grove J, Stephens C, Lucena M, Andrade R, Weber S, Gerbes A, et al.
Diagn Progn Res
. 2023 Sep;
7(1):18.
PMID: 37697410
A lack of biomarkers that detect drug-induced liver injury (DILI) accurately continues to hinder early- and late-stage drug development and remains a challenge in clinical practice. The Innovative Medicines Initiative's...
5.
Lange C, Trebicka J, Gerbes A, Canbay A, Geier A, Merle U, et al.
Liver Int
. 2023 Aug;
43(11):2503-2512.
PMID: 37602977
Background And Aims: Data on number of patients with cirrhosis in Germany are limited. We therefore aimed to estimate prevalence, comorbidities, mortality, utilization of healthcare resources and costs of patients...
6.
Andrade R, Aithal G, de Boer Y, Liberal R, Gerbes A, Regev A, et al.
J Hepatol
. 2023 May;
79(3):853-866.
PMID: 37164270
Drug-induced liver injury (DILI) can mimic almost all other liver disorders. A phenotype increasingly ascribed to drugs is autoimmune-like hepatitis (ALH). This article summarises the major topics discussed at a...
7.
Bjornsson E, Stephens C, Atallah E, Robles-Diaz M, Alvarez-Alvarez I, Gerbes A, et al.
Liver Int
. 2022 Jul;
43(1):115-126.
PMID: 35899490
Background & Aims: No multi-national prospective study of drug-induced liver injury (DILI) has originated in Europe. The design of a prospective European DILI registry, clinical features and short-term outcomes of...
8.
Allgeier J, Weber S, Todorova R, Neumann J, Gerbes A
Eur J Gastroenterol Hepatol
. 2022 Mar;
34(4):457-461.
PMID: 35230981
Background And Aim: Drug-induced liver injury (DILI) remains a challenging diagnosis requiring exclusion of other causes of liver injury, concise medical history taking to identify potential causative medication and creation...
9.
Trebicka J, Fernandez J, Papp M, Caraceni P, Laleman W, Gambino C, et al.
J Hepatol
. 2020 Nov;
74(5):1097-1108.
PMID: 33227350
Background & Aims: Acute decompensation (AD) of cirrhosis may present without acute-on-chronic liver failure (ACLF) (AD-No ACLF), or with ACLF (AD-ACLF), defined by organ failure(s). Herein, we aimed to analyze...
10.
Wong F, Piano S, Singh V, Bartoletti M, Maiwall R, Alessandria C, et al.
J Hepatol
. 2020 Aug;
74(2):330-339.
PMID: 32781201
Background & Aims: Bacterial infections can trigger the development of organ failure(s) and acute-on-chronic liver failure (ACLF). Geographic variations in bacteriology and clinical practice could lead to worldwide differences in...